Search results for: 'WA 0859 3970 0884 RAB Renovasi Rumah 2 Lantai Lebar 5 Meter Berpengalaman Tempel Sleman'

This panel includes the specific tests to be performed for Border Collie: hyperuricosuria  (DOG-HUU), Imerslund-Gräsbeck syndrome (DOG-IGSB), myotonia congenita (DOG-MC), Multidrug Resistance (DOG-MDR1), malignant hyperthermia (DOG-MH), neuronal ceroid lipofuscinosis type 5 (DOG-NCL5), dental hypomineralisation (DOG-RAINE) and trapped neutrophil syndrome (DOG-TNS).

This pack includes the recommended tests defined by the Flemish breeding program for Border Collie: Exercise-induced collapse (DOG-EIC), Myotonia Congenita (DOG-MC), Neuronal ceroid lipofuscinosis type 5 (DOG-NCL5), Progressive rod-cone degeneration (DOG-PRA-PRCD), sensory neuropathy (DOG-SN) and Von Willebrand disease type 1 (DOG-VWD1).

 

The Flemish breeding program also requires the tests included in our DOG-COLLIE-VL pack.

Progressive retinal atrophy (PRA) causes visual impairment due to the degeneration of the photoreceptors in the retina. Symptoms usually appear from the age of 5 years.

This panel includes the essential tests to be performed for the Golden Retriever: muscular dystrophy (DOG-GRMD), Neuronal ceroid lipofuscinosis type 5 (DOG-NCLA5GR), osteogenesis imperfecta (DOG-OSTEO-GR).

Benign familial juvenile epilepsy is a disease in which clinical signs appear between 5 and 12 weeks of age. Affected dogs exhibit convulsions characterised by generalised tremors, ataxia and stiffness.

Cone-rod dystrophy 2 is a form of progressive retinal atrophy characterised by an early, severe and rapidly progressive loss of cone function accompanied by a progressive loss of rods.

A horse’s height depends on genetic and environmental factors. A genetic variation in the regulatory region of the LCORL gene strongly influences the height of warmblood horses (+/- 5 cm). The effect of this variation is less predictable in non-warmblood breeds.

Progressive retinal atrophy causes blindness due to the destruction of the photoreceptors in the retina. The loss of vision begins at the age of 7 months and gradually declines until it is almost complete by the age of 3 to 5 years.

This panel includes the specific tests to be performed for the Golden Retriever: Dystrophic epidermolysis bullosa (DOG-DEB), muscular dystrophy (DOG-GRMD), Ichtyosis (DOG-ICHGR), Neuronal ceroid lipofuscinosis type 5 (DOG-NCL5GR), osteogenesis imperfecta (DOG-OSTEO-GR), progressive retinal atrophy (DOG-PRA1-GR) and progressive rod-cone degeneration (DOG-PRA-PRCD).

Pyruvate kinase is an essential enzyme for energy production in red blood cells. Clinical signs are anaemia, weakness, hepatosplenomegaly. Bone marrow and liver failure usually occur before the age of 5 years. Heterozygous animals (healthy carriers) show no clinical signs, but have reduced levels of pyruvate kinase activity. Bone marrow transplants have been used to alleviate clinical signs in affected dogs.